Evidence map›Paper›PMID 21430254›Full record

Trial reportThe Journal of nutrition2011

Mammalian target of rapamycin complex 1 activation is required for the stimulation of human skeletal muscle protein synthesis by essential amino acids.

Jared M Dickinson, Christopher S Fry, Micah J Drummond, David M Gundermann, Dillon K Walker, Erin L Glynn, Kyle L Timmerman, Shaheen Dhanani, Elena Volpi, Blake B Rasmussen

2 registry-linked trialsAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The Journal of nutrition, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 148 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
148citing papers in PubMed, 2 pooled it
10.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00891696 phase1completednot on this map

Nutritional and Contractile Regulation of Muscle Growth (Cycle 2)

TypeinterventionalSponsorThe University of Texas Medical Branch, GalvestonRan2009 to 2015Enrolled144ConditionsSarcopeniaArmsRapamycin, Amino acid supplementation, Low-intensity resistance exercise, Sodium nitroprusside, Blood flow restriction cuff
NCT04784806 nacompletednot on this mapstarted 2021, after this paper: background citation

Amino Acid Profile and Muscle Protein Synthetic Response to Consuming Meat or Plant-based Alternatives

TypeinterventionalSponsorUniversity of California, DavisRan2021 to 2021Enrolled17ConditionsHealthyArmsGround beef, Ground pork, Tofu, Beyond Meat
3 · Its place in the literature

Who cites it

148 citing papers in PubMed, 2 syntheses or guidelines pooled it, 282 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Article
  20. Review

88 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Jared M DickinsonDivision of Rehabilitation Sciences, University of Texas Medical Branch, Galveston, TX 77555, USA.
Christopher S Fry
Micah J Drummond
David M Gundermann
Dillon K Walker
Erin L Glynn
Kyle L Timmerman
Shaheen Dhanani
Elena Volpi
Blake B Rasmussen
The University of Texas Medical Branch at Galveston · US

Funding

UTMB OAIC Research Education Component (REC)P30AG024832 · NIA · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI JAMES S. GOODWIN, MD, MELISSA M. MORROW · 2005 to 2026
$26.7M
UTMB CLINICAL AND TRANSLATIONAL SCIENCE AWARD: NASA BED REST STUDIESUL1RR029876 · NCRR · UNIVERSITY OF TEXAS MED BR GALVESTON · PI BRASIER, ALLAN R. · 2009 to 2011
$17.7M
UTMB Clinical and Translational Science AwardUL1TR000071 · NCATS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI BRASIER, ALLAN R. · 2012 to 2014
$14.4M
Nutritional and Contractile Regulation of Muscle GrowthR01AR049877 · NIAMS · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI RASMUSSEN, BLAKE B · 2004 to 2012
$3.3M
Interdisciplinary Rehabilitation Research TrainingT32HD007539 · NICHD · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI OTTENBACHER, KENNETH J. · 2001 to 2011
$1.1M
NCATS NIH HHS UL1 TR000071NCRR NIH HHS 1UL1RR029876-01NCRR NIH HHS UL1 RR029876NIAMS NIH HHS R01 AR049877NIA NIH HHS P30 AG024832NIA NIH HHS P30AG024832NICHD NIH HHS T32 HD007539NICHD NIH HHS T32-HD07539
6 · The paper itself

Abstract

The relationship between mammalian target of rapamycin complex 1 (mTORC1) signaling and muscle protein synthesis during instances of amino acid surplus in humans is based solely on correlational data. Therefore, the goal of this study was to use a mechanistic approach specifically designed to determine whether increased mTORC1 activation is requisite for the stimulation of muscle protein synthesis following L-essential amino acid (EAA) ingestion in humans. Examination of muscle protein synthesis and signaling were performed on vastus lateralis muscle biopsies obtained from 8 young (25 ± 2 y) individuals who were studied prior to and following ingestion of 10 g of EAA during 2 separate trials in a randomized, counterbalanced design. The trials were identical except during 1 trial, participants were administered a single oral dose of a potent mTORC1 inhibitor (rapamycin) prior to EAA ingestion. In response to EAA ingestion, an ~60% increase in muscle protein synthesis was observed during the control trial, concomitant with increased phosphorylation of mTOR (Ser(2448)), ribosomal S6 kinase 1 (Thr(389)), and eukaryotic initiation factor 4E binding protein 1 (Thr(37/46)). In contrast, prior administration of rapamycin completely blocked the increase in muscle protein synthesis and blocked or attenuated activation of mTORC1-signaling proteins. The inhibition of muscle protein synthesis and signaling was not due to differences in either extracellular or intracellular amino acid availability, because these variables were similar between trials. These data support a fundamental role for mTORC1 activation as a key regulator of human muscle protein synthesis in response to increased EAA availability. This information will be useful in the development of evidence-based nutritional therapies targeting mTORC1 to counteract muscle wasting associated with numerous clinical conditions.

Indexed as

Enzyme ActivationSignal TransductionUp-RegulationAdaptor Proteins, Signal TransducingAdultAmino Acids, EssentialBiopsy, NeedleCell Cycle ProteinsFemaleHumansKineticsMaleMechanistic Target of Rapamycin Complex 1Multiprotein ComplexesMuscle ProteinsMuscle, SkeletalAdaptor Proteins, Signal TransducingAmino Acids, EssentialCell Cycle ProteinsEIF4EBP1 protein, humanMechanistic Target of Rapamycin Complex 1MTOR protein, humanMultiprotein ComplexesMuscle ProteinsPhosphoproteinsProtein Kinase InhibitorsProteinsRibosomal Protein S6 Kinases, 90-kDaRPS6KA1 protein, humanSirolimusTOR Serine-Threonine Kinases

Identifiers

PMID21430254
PMCPMC3077888
OpenAlexW2116606180

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.